MissionIRNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in Canaccord Genuity Growth Conference 

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.  Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company developing novel serotonergic agonists (“NSAs”), announced that CEO Michael Halstead will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, taking place Aug. 11-12, 2026. The fireside chat will be webcast live Aug. 12 at noon EDT, with […]